He aha ka Adalimumab-aacf: Nā hoʻohana, ka nui o ka lāʻau, nā hopena ʻaoʻao a me nā mea hou aku

ʻO Adalimumab-aacf he lāʻau lapaʻau i kauoha ʻia e kōkua i ka hoʻomaha ʻana i kāu ʻōnaehana pale i ka wā e hoʻouka ana i kou kino ponoʻī. ʻO ia ka mea a nā kauka e kapa ai he biosimilar, ʻo ia hoʻi, hana like ia me ka lāʻau adalimumab mua akā hana ʻia e kahi hui ʻē aʻe e hāʻawi i nā koho lapaʻau kūpono.

No kēia lāʻau lapaʻau i kahi hui i kapa ʻia ʻo TNF blockers, a hāʻawi ʻia ma ke ʻano he injection ma lalo o kou ʻili. Nui ka poʻe me nā maʻi autoimmune e like me ka rheumatoid arthritis, Crohn's disease, a i ʻole psoriasis e ʻike i ke kōkua nui me kēia lapaʻau.

No ke aha e hoʻohana ʻia ai ka Adalimumab-aacf?

Hoʻomaʻamaʻa ʻo Adalimumab-aacf i kekahi mau maʻi kahi e hoʻouka hewa ai kāu ʻōnaehana pale i nā ʻāpana olakino o kou kino. Hiki i kāu kauka ke kauoha iā ia i ka wā i hāʻawi ʻole ai nā lāʻau lapaʻau ʻē aʻe i ka lawa ʻana o ke kōkua a i ʻole ke pono ʻoe i ka lāʻau ikaika e mālama i kāu mau hōʻailona.

Hoʻohana pinepine ʻia ka lāʻau lapaʻau no ka rheumatoid arthritis, kahi e kōkua ai i ka hōʻemi ʻana i ka ʻeha hui a me ka pehu ʻana i ka wā e lohi ai ka pōʻino hui. Hiki iā ia ke hana i kahi ʻokoʻa maoli i kou hōʻoluʻolu i kēlā me kēia lā a me ka neʻe ʻana.

No nā maʻi ʻōpū inflammatory e like me ka maʻi Crohn a me ka ulcerative colitis, kōkua ʻo adalimumab-aacf i ka hoʻōla ʻana i ka laina ʻōpū a hoʻemi i nā flare-ups ʻeha. Nui ka poʻe e ʻike i nā huakaʻi lumi ʻauʻau liʻiliʻi a me ka liʻiliʻi o ka ʻeha o ka ʻōpū.

Inā loaʻa iā ʻoe ka psoriasis a i ʻole psoriatic arthritis, hiki i kēia lāʻau lapaʻau ke hoʻomaʻemaʻe i nā ʻili ʻili a hoʻemi i ka mumū hui. ʻO ka hoʻomaikaʻi ʻana i ka helehelena o ka ʻili e hoʻonui pinepine i ka hilinaʻi me ke kōkua kino.

ʻO nā maʻi ʻē aʻe e pōmaikaʻi paha me ka ankylosing spondylitis (he ʻano arthritis spine), hidradenitis suppurativa (nā puʻupuʻu ʻili ʻeha), a me kekahi mau ʻano o ka mumū maka i kapa ʻia ʻo uveitis.

Pehea ka hana a Adalimumab-aacf?

Hana ʻo Adalimumab-aacf ma ka pale ʻana i kahi protein i loko o kou kino i kapa ʻia ʻo tumor necrosis factor (TNF). E noʻonoʻo i ka TNF he kiaʻi palekana nui loa e hana ana i ka mumū nui loa i ka wā e pale aku ai iā ʻoe.

I ka wā e loaʻa ai iā ʻoe kahi maʻi autoimmune, hana kou kino i ka nui o ka TNF, e alakaʻi ana i ka mumū mau, ka ʻeha, a me ka pōʻino o ka ʻiʻo. Hana kēia lāʻau lapaʻau e like me ke kiaʻi mālie, e haʻi ana i kēlā kiaʻi palekana hana nui e mālie.

Ma ka hoʻemi ʻana i ka hana TNF, kōkua ʻo adalimumab-aacf i ka hoʻemi ʻana i ka mumū ma kou kino. Hiki i kēia ke alakaʻi i ka liʻiliʻi o ka ʻeha, ka pehu ʻana, a me ka hana maikaʻi ʻana ma nā wahi i hoʻopilikia ʻia e like me nā hui a i ʻole nā ʻōpū.

Ua manaʻo ʻia he lāʻau lapaʻau ikaika e hana hohonu ana i loko o kāu ʻōnaehana pale. ʻOiai he ikaika a maikaʻi, pono ia i ka nānā pono ʻana no ka mea e pili ana i nā hana pale kūlohelohe o kou kino.

Pehea wau e lawe ai iā Adalimumab-aacf?

Hāʻawi ʻia ʻo Adalimumab-aacf ma ke ʻano he injection ma lalo o kou ʻili, maʻamau i kou ʻūhā a i ʻole ka ʻōpū. E aʻo kāu hui mālama ola iā ʻoe pehea e hoʻokomo ai iā ʻoe iho ma ka home, a i ʻole hiki i kahi lālā o ka ʻohana ke aʻo e kōkua iā ʻoe.

Lawe ka hapa nui o nā kānaka i kēia lāʻau lapaʻau i kēlā me kēia pule ʻē aʻe, ʻoiai paha e hoʻoponopono kāu kauka i ka papa manawa ma muli o kou kūlana a me ka pane. Hele mai ka injection i loko o kahi peni i hoʻopiha mua ʻia a i ʻole ka syringe e maʻalahi ai ke kaʻina hana.

Hiki iā ʻoe ke lawe i kēia lāʻau lapaʻau me ka ʻole o ka meaʻai no ka mea ua hoʻokomo ʻia ma mua o ka ʻai ʻana. Eia naʻe, he mea nui e ʻae i ka lāʻau lapaʻau e hiki i ka mahana o ka lumi ma mua o ka hoʻokomo ʻana, e lawe ana ma kahi o 15 a 30 mau minuke ma hope o ka wehe ʻana mai ka pahu hau.

E mālama i kāu lāʻau lapaʻau i loko o ka pahu hau akā ʻaʻole loa e paʻahau. E mālama i loko o kāna pūʻolo kumu e pale iā ia mai ka mālamalama, a mai lulu i ka pahu no ka mea hiki i kēia ke hōʻino i ka lāʻau lapaʻau.

E hoʻololi mau i nā wahi e hoʻokomo ai i ka lāʻau e pale ai i ka huhū o ka ʻili. ʻO nā wahi maikaʻi e komo pū ana i mua o kou ʻūhā a me kou ʻōpū, e pale ana i nā wahi palupalu, ʻeha, a i ʻole nā ʻōpala.

Pehea ka lōʻihi e lawe ai au i ka Adalimumab-aacf?

He ʻokoʻa nui ka lōʻihi o ka mālama ʻana me ka adalimumab-aacf ma muli o kou maʻi a me ka maikaʻi o kou pane ʻana i ka lāʻau. Nui ka poʻe e lawe ana i ka lāʻau no nā mahina a i ʻole nā makahiki e mālama i ka mana o kā lākou mau hōʻailona.

No nā maʻi e like me ka rheumatoid arthritis a i ʻole ka maʻi ʻōpū mumū, pono pinepine ka mālama ʻana i ka wā lōʻihi no ka mea he mau maʻi maʻi kēia e koi ana i ka mālama mau. ʻO ka hoʻōki ʻana i ka lāʻau i ka wā mua e alakaʻi pinepine i ka hoʻi ʻana mai o nā hōʻailona.

E nānā mau kāu kauka i kāu pane a hiki ke hoʻololi i kāu hoʻolālā lapaʻau ma muli o kou manaʻo a me nā hopena o kāu lab. Hiki i kekahi poʻe ke hoʻomaha mai ka lāʻau inā loaʻa iā lākou ka remission, ʻoiai nā mea ʻē aʻe e pono i ka mālama mau.

ʻO ka pahuhopu ka loaʻa ʻana o ke kaulike kūpono ma waena o ka mālama ʻana i kou maʻi a me ka hōʻemi ʻana i nā pilikia. E hana pū kāu hui mālama ola me ʻoe e hoʻoholo i ka lōʻihi maikaʻi loa no kāu kūlana.

He aha nā hopena ʻaoʻao o Adalimumab-aacf?

E like me nā lāʻau lapaʻau a pau e pili ana i kāu ʻōnaehana pale, hiki i ka adalimumab-aacf ke hana i nā hopena ʻaoʻao, ʻoiai ua ʻae maikaʻi ka poʻe he nui. ʻO ka hoʻomaopopo ʻana i ka mea e nānā ai e kōkua iā ʻoe e manaʻoʻiʻo i kāu lapaʻau.

ʻO nā hopena ʻaoʻao maʻamau e hiki iā ʻoe ke ʻike e komo pū ana me nā hopena ma ka pūnaewele injection, e like me ka ʻulaʻula, ka pehu, a i ʻole ka ʻeha maʻalahi kahi i loaʻa ai iā ʻoe ka pana. He maʻalahi kēia mau hopena a hoʻomaikaʻi iā lākou iho i loko o kekahi mau lā.

Eia nā hopena ʻaoʻao pinepine e hōʻike ai ka poʻe:

• Nā maʻi o ka ʻōnaehana hanu luna e like me ke anu a i ʻole nā maʻi sinus
• Nā ʻeha poʻo i maʻalahi a i ʻole waena
• Nā hopena ma kahi i hoʻokomo ʻia ai ka lāʻau, me ka ʻulaʻula a i ʻole ka ʻū
• Luhi a i ʻole ka manaʻo e luhi ana ma mua o ka maʻamau
• Nausea a i ʻole ka ʻōpū e ʻeha ana
• Pāpaʻa ʻili a i ʻole ka ʻū ʻana ma nā wahi ʻē aʻe ma mua o kahi i hoʻokomo ʻia ai ka lāʻau

He mea maʻamau kēia mau hopena ʻaoʻao a hiki ke hoʻoponopono ʻia a maʻa mau e hoʻomaikaʻi ana i ka wā e hoʻopili ai kou kino i ka lāʻau. Hiki i kāu kauka ke hōʻike i nā ala e hōʻemi ai i ka ʻoluʻolu ʻole inā loaʻa kēia mau mea.

ʻAʻole maʻamau nā hopena ʻaoʻao koʻikoʻi, akā pono e mālama koke ʻia. No ka mea e pili ana ka adalimumab-aacf i kāu ʻōnaehana pale, hiki iā ia ke hoʻonui iā ʻoe i nā maʻi.

E nānā i nā hōʻailona o ka maʻi koʻikoʻi, me ke kuni mau, ka luhi ʻole, nā hōʻailona e like me ka maʻi flu ʻaʻole e hoʻomaikaʻi, a i ʻole nā hōʻailona o ka maʻi tuberculosis e like me ka ʻū mau a i ʻole ka emi ʻana o ke kaumaha. Pono kēia mau mea i ka loiloi olakino wikiwiki.

ʻAʻole maʻamau akā hiki i nā hopena ʻaoʻao koʻikoʻi ke komo i nā hopena maʻi koʻikoʻi, nā pilikia o ke ake, nā maʻi koko, a i ʻole ka ulu ʻana o kekahi mau ʻano maʻi ʻaʻai. ʻOiai ʻaʻole maʻamau kēia mau mea, e nānā mau kāu kauka iā ʻoe me nā hoʻokolohua koko a me nā nānā.

Hiki i kekahi poʻe ke ʻike i nā pilikia o ka ʻōnaehana nerve, ka hōʻino ʻana o ka puʻuwai, a i ʻole ka ulu ʻana o nā hōʻailona e like me ka lupus. He mea maʻamau ʻole kēia mau mea, akā he mea nui e hōʻike i nā hōʻailona ʻē i kāu mea mālama ola.

ʻO wai ka mea ʻaʻole pono e lawe i ka Adalimumab-aacf?

ʻAʻole kūpono ka Adalimumab-aacf no nā mea a pau, a e nānā pono kāu kauka i kāu moʻolelo olakino ma mua o ke kau ʻana. ʻO kekahi mau kūlana a i ʻole nā kūlana e hoʻoweliweli loa ai kēia lāʻau lapaʻau e hoʻohana palekana.

ʻAʻole pono ʻoe e lawe i kēia lāʻau lapaʻau inā loaʻa iā ʻoe kahi maʻi ikaika, me ka maʻi tuberculosis, hepatitis B, a i ʻole kekahi maʻi bacteria, viral, a i ʻole fungal koʻikoʻi. Pono e hiki i kāu ʻōnaehana pale ke hakakā pono i kēia mau maʻi.

ʻO ka poʻe me kekahi mau ʻano maʻi maʻi, ʻo ia hoʻi ka lymphoma a i ʻole nā maʻi koko ʻē aʻe, pono e pale i kēia lāʻau. Hiki i ka hoʻopaʻa ʻana i ka ʻōnaehana pale ke hoʻonui i kēia mau maʻi.

Inā he maʻi puʻuwai koʻikoʻi a koʻikoʻi paha kāu, ʻaʻole kūpono paha ka adalimumab-aacf no ka mea hiki ke hoʻonui i kou maʻi puʻuwai. Pono kāu cardiologist a me rheumatologist e hana pū e hoʻoholo i ka palekana.

Eia nā maʻi koʻikoʻi ʻē aʻe e pale ai iā ʻoe mai ka lawe ʻana i kēia lāʻau:

• Hepatitis B a i ʻole hepatitis C maʻi
• Mōʻaukala o ka maʻi tuberculosis i mālama ʻole ʻia
• Maʻi kīkī a i ʻole maʻi ate koʻikoʻi
• Nā lāʻau lapaʻau ola hou a i ʻole nā hoʻolālā e loaʻa ai nā lāʻau lapaʻau ola
• Hāpai a i ʻole ka hānai ʻana i ka waiū (pono ka noʻonoʻo kūikawā)
• Multiple sclerosis a i ʻole nā maʻi demyelinating ʻē aʻe

E noʻonoʻo pū kāu kauka i nā lāʻau lapaʻau āu e lawe nei, no ka mea, hiki i kekahi mau hui ke hoʻonui i ka pilikia o ka maʻi a i ʻole e hōʻemi i ka pono. E hāʻawi mau i kahi papa inoa piha o nā lāʻau lapaʻau a me nā mea hoʻohui āu e hoʻohana ai.

Inoa Brand Adalimumab-aacf

Loaʻa ka Adalimumab-aacf ma lalo o ka inoa brand Yusimry. ʻO kēia ka mana biosimilar o ka lāʻau adalimumab kumu, i kūʻai ʻia ma lalo o ka inoa brand Humira.

Hoʻolālā ʻia nā Biosimilars e like me Yusimry e hana like me ka lāʻau kumu akā ʻoi aku ka liʻiliʻi o ke kumukūʻai. Ua ʻae ka FDA iā ia me ka ʻole o nā ʻokoʻa lapaʻau koʻikoʻi mai ka adalimumab kumu.

Hiki i kāu lāʻau lapaʻau ke lawe iā ia ma lalo o ka inoa generic adalimumab-aacf a i ʻole ka inoa brand Yusimry. E pili ana nā mea ʻelua i ka lāʻau lapaʻau like, no laila, mai hopohopo inā ʻike ʻoe i nā inoa like ʻole ma kāu ʻōmole kuhikuhi.

Nā koho ʻē aʻe Adalimumab-aacf

Inā ʻaʻole maikaʻi ka adalimumab-aacf iā ʻoe a i ʻole e hana ana i nā hopena ʻaoʻao pilikia, aia kekahi mau lāʻau lapaʻau ʻē aʻe i loaʻa. Hiki i kāu kauka ke kōkua iā ʻoe e ʻimi i nā koho ʻē aʻe i kūpono i kou kūlana.

ʻO nā mea pale TNF ʻē aʻe e komo pū ana me etanercept (Enbrel), infliximab (Remicade), a me golimumab (Simponi). Hana like kēia mau mea me adalimumab akā ʻoi aku ka maikaʻi o ka ʻae ʻia e kekahi poʻe a i ʻole ʻoi aku ka maikaʻi no kekahi mau maʻi.

Hāʻawi nā lāʻau lapaʻau biologic non-TNF i nā ala like ʻole i ka mālama ʻana i nā maʻi autoimmune. ʻO kēia mau mea e komo pū ana me rituximab (Rituxan), abatacept (Orencia), a me tocilizumab (Actemra), e manaʻo ana i nā ʻāpana like ʻole o ka ʻōnaehana pale.

No kekahi mau maʻi, hiki i nā lāʻau lapaʻau waha hou e like me nā mea pale JAK ke koho. ʻO kēia mau mea e komo pū ana me tofacitinib (Xeljanz) a me baricitinib (Olumiant), e hele mai ana i ke ʻano o ka pila ma mua o nā injections.

Hiki ke hoʻohana ʻia nā lāʻau lapaʻau hoʻololi maʻi maʻamau e like me methotrexate, sulfasalazine, a i ʻole leflunomide wale nō a i ʻole i hui pū ʻia me nā biologics. Hoʻāʻo pinepine ʻia kēia mau mea ma mua o ka neʻe ʻana i nā lāʻau lapaʻau ikaika.

Ua ʻoi aku ka maikaʻi o Adalimumab-aacf ma mua o Humira?

Aia i loko o Adalimumab-aacf (Yusimry) a me Humira ka mea hana like a hana ma nā ala like. ʻO ka ʻokoʻa nui ʻo ka adalimumab-aacf he biosimilar, ʻo ia ka mea maʻamau e emi ke kumukūʻai ma mua o ka Humira kumu.

Hōʻike nā haʻawina lapaʻau e like ka maikaʻi o adalimumab-aacf me Humira no ka mālama ʻana i nā maʻi autoimmune. Pono ka FDA i nā biosimilars e hōʻike e hana maikaʻi lākou e like me ka lāʻau lapaʻau kumu ma mua o ka ʻae ʻia.

Loaʻa i nā lāʻau lapaʻau ʻelua nā ʻano hopena ʻaoʻao like a me nā manaʻo palekana. Inā ua lawe ʻoe iā Humira me ka holomua, ʻo ka hoʻololi ʻana i adalimumab-aacf e hāʻawi i nā pōmaikaʻi like me ka mālama kālā.

ʻO ke koho ma waena o lākou e pili pinepine ana i ka uhi ʻana o ka ʻinikua a me ke kumukūʻai. Nui nā hoʻolālā ʻinikua e makemake i ka koho biosimilar ʻoi aku ka liʻiliʻi, ʻoiai makemake kekahi poʻe e noho me ka lāʻau lapaʻau kumu a lākou i ʻike ai e hana ana no lākou.

Hiki i kāu kauka ke kōkua iā ʻoe e hoʻoholo i ke koho e kūpono loa ana no kou kūlana kikoʻī, me ka noʻonoʻo ʻana i nā mea lapaʻau a me nā mea kālā.

Nā Nīnau i Nīnau Pinepine ʻia e pili ana iā Adalimumab-aacf

Q1. Palekana anei ʻo Adalimumab-aacf no ka maʻi diabetes?

Hiki ke hoʻohana palekana ʻia ʻo Adalimumab-aacf i ka poʻe me ka maʻi diabetes, akā pono ia i ka nānā pono ʻana. ʻAʻole pili pololei ka lāʻau lapaʻau i nā pae kōpaʻa koko, akā hiki i nā maʻi (ʻoi aku ka maʻalahi o ʻoe) ke paʻakikī i ka mālama ʻana i ka maʻi diabetes.

Makemake kāu kauka e hōʻoia i ka mālama pono ʻia ʻana o kāu maʻi diabetes ma mua o ka hoʻomaka ʻana i kēia lāʻau lapaʻau. Kōkua ka mālama maikaʻi ʻana i ke kōpaʻa koko i kāu ʻōnaehana pale e hana maikaʻi a hoʻemi i ka pilikia o ka maʻi.

He mea nui ka nānā mau ʻana ke loaʻa iā ʻoe nā kūlana ʻelua. E nānā i nā hōʻailona o nā maʻi e pili ana i kāu kōpaʻa koko, a e mālama i kāu hui mālama ola diabetes i ka ʻike e pili ana i kāu lapaʻau adalimumab-aacf.

Q2. He aha kaʻu e hana ai inā ua hoʻohana hewa au i ka nui o Adalimumab-aacf?

Inā ʻoe e hoʻokomo hewa i ka nui o adalimumab-aacf ma mua o ka mea i kauoha ʻia, e hoʻokaʻaʻike koke i kāu kauka a i ʻole ka mea mālama ola. ʻOiai he kakaikahi nā overdoses me kēia lāʻau lapaʻau, he mea nui e kiʻi i ke alakaʻi lapaʻau i kēia manawa.

Mai hopohopo, akā e ʻimi i ka lāʻau lapaʻau wikiwiki. ʻO ka hopohopo nui me ka nui o ka lāʻau lapaʻau he piʻi ka pilikia o ka maʻi a i ʻole nā hopena ʻē aʻe o ka ʻōnaehana pale e pono ai ka nānā ʻana.

E mālama i ka nui o ka lāʻau lapaʻau keu āu i lawe ai a i ka wā i hana ʻia ai. E kōkua kēia ʻike i kāu mea mālama ola e hoʻoholo i ke ala maikaʻi loa o ka hana a inā pono ka nānā hou ʻana.

Q3. He aha kaʻu e hana ai inā ua hala au i kahi mahele o Adalimumab-aacf?

Inā ʻoe e poina i ka lāʻau adalimumab-aacf, e lawe koke ʻoe i ka wā e hoʻomanaʻo ai ʻoe, ke ʻole ua kokoke ka manawa no kāu lāʻau i hoʻonohonoho ʻia e hiki mai ana. Ma ia hihia, e lele i ka lāʻau i poina a e hoʻomau me kāu papa hana maʻamau.

Mai lawe i ʻelua lāʻau i ka manawa hoʻokahi e uku ai i ka lāʻau i poina. Hiki i kēia ke hoʻonui i kou pilikia o nā hopena ʻaoʻao me ka ʻole e hāʻawi i ka pōmaikaʻi hou.

Inā ʻaʻole ʻoe maopopo e pili ana i ka manawa a i ʻole ua poina i kekahi mau lāʻau, e hoʻokaʻaʻike i kāu mea mālama ola no ke alakaʻi. Hiki iā lākou ke hoʻoponopono i kāu papa hana a i ʻole e hāʻawi i nā ʻōlelo kikoʻī e pili ana i kou kūlana.

Q4. I ka manawa hea e hiki ai iaʻu ke hooki i ka lawe ʻana iā Adalimumab-aacf?

Mai hooki i ka lawe ʻana iā adalimumab-aacf me ka ʻole e kūkākūkā mua me kāu kauka. ʻO ka hooki koke ʻana hiki ke alakaʻi i ka piʻi ʻana o kou maʻi, a ʻoi aku paha ka paʻakikī o ka mālama ʻana ma mua o kou hoʻomaka ʻana i ka lāʻau.

E kōkua kāu kauka iā ʻoe e hoʻoholo i ka manawa e kūpono ai ke hooki a i ʻole e hoʻomaha mai ka lāʻau. Aia kēia hoʻoholo i ka maikaʻi o ka mālama ʻia ʻana o kou maʻi a me kou kūlana olakino holoʻokoʻa.

Hiki i kekahi poʻe ke hōʻemi i kā lākou lāʻau a i ʻole e hooki i ka lāʻau inā e loaʻa iā lākou ka hoʻokuʻu lōʻihi. Pono nā mea ʻē aʻe e hoʻomau i ka lāʻau no ka manawa pau ʻole e mālama i ko lākou olakino a me ka maikaʻi o ke ola.

Q5. Hiki iaʻu ke loaʻa nā lāʻau lapaʻau i ka wā e lawe ana iā Adalimumab-aacf?

Hiki iā ʻoe ke loaʻa ka hapa nui o nā lāʻau lapaʻau i ka wā e lawe ana iā adalimumab-aacf, akā pono ʻoe e pale i nā lāʻau lapaʻau ola. E ʻōlelo kāu kauka e loaʻa i kekahi mau lāʻau lapaʻau ma mua o ka hoʻomaka ʻana i ka lāʻau inā hiki.

Pono e pale ʻia nā lāʻau lapaʻau ola e like me ka lāʻau flu nasal, MMR, a i ʻole varicella (chickenpox) no ka mea ʻaʻole paha e mālama pono kāu ʻōnaehana pale i nā mea palekana. E pili i nā lāʻau lapaʻau i hoʻopau ʻia.

He mea nui loa e noho i kēia manawa me kāu pana flu, ka lāʻau pneumonia, a me nā lāʻau lapaʻau ʻē aʻe a kāu kauka e ʻōlelo ai. Hiki i kēia mau mea ke kōkua iā ʻoe e pale aku i nā maʻi i ka wā e hana ʻole ai kāu ʻōnaehana pale.